Summary
- Current Price
- As of today, RYTM price is $104.71, up +2.46% on
- Current Price All-Time High
- RYTM price is currently -14.31% below its historical high of $122.20 set on
- Market Cap
- RYTM current market cap is $7B, up +15.20% over the past 365 days
- Revenue
- RYTM current annual revenue is $189.76M, up +45.83% year-over-year
- Next Earnings
- The next earnings release for RYTM is on
Profile
| Metric | Value |
|---|---|
| Full Name | Rhythm Pharmaceuticals, Inc. |
| Ticker | NASDAQ: RYTM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | rhythmtx.com |
| Employees | 283 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $104.71 | |
| Price, 1D Change | +2.46% | |
| $7B | ||
| - | ||
| - | ||
| 0.98 | ||
| $189.76M | ||
| Revenue, 1Y Change | +45.83% | |
| -$3.11 | ||
| EPS, 1Y Change | +28.37% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.11 | ||
| EPS Estimate | -$3.07 | N/A |
| EPS Est. Change | +1.05% | N/A |
| $189.76M | ||
| Revenue Estimate | $313.73M | N/A |
| Revenue Est. Change | +65.33% | N/A |
| Current Price | $104.71 | |
| Price Target | $144.00 | - |
| Price Tgt. Change | +37.52% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.07 | -$4.34 | -6.57% | |
| -$3.11 | -$3.11 | +0.18% | |
| -$3.07 | N/A | +1.05% | |
| -$0.61 | N/A | +80.23% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $126.95M | $130.13M | +2.50% | |
| $188.98M | $189.76M | +0.41% | |
| $313.73M | N/A | +65.33% | |
| $560.25M | N/A | +195.24% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $104.71 | |
| $99.61 | ||
| $108.88 | ||
| $98.62 | ||
| $106.35 | ||
| -$1.90 | ||
| 0.98 | ||
| $4.21 | ||
| 44.73 | ||
| 30.85% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $189.76M | ||
| -$3.11 | ||
| $170.27M | ||
| 89.50% | ||
| -$192.02M | ||
| -101.19% | ||
| -$196.54M | ||
| -103.57% | ||
| -$190.68M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.97 | ||
| 4.41 | ||
| 4.16 | ||
| - | ||
| 4 | ||
| 8.69 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 30.05 | ||
| 70.01 | ||
| -35.02 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $139.07M | ||
| $388.95M | ||
| $481.19M | ||
| $466.92M | ||
| $342.13M | ||
| $105.94M | ||
| $134.95M | ||
| $650.00K | ||
| $13.95M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $386.30M | ||
| $362.28M | ||
| $19.49M | ||
| $194.94M | ||
| $1.34M | ||
| $0.00 | ||
| $497.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$115.68M | ||
| -$137.15M | ||
| $217.96M | ||
| $40.95M | ||
| -$156.63M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Deutsche Bank | ||
| JP Morgan | → | |
| RBC Capital | → | |
| Citizens | → | |
| Citigroup | → | |
| JP Morgan | ||
| RBC Capital | → | |
| Canaccord Genuity | → | |
| Wells Fargo | → | |
| Canaccord Genuity | → |
Analyst sentiment
Institutional ownership
No data
Screeners with RYTM
FAQ
- What is the ticker symbol for Rhythm Pharmaceuticals, Inc.?
- The ticker symbol for Rhythm Pharmaceuticals, Inc. is NASDAQ:RYTM
- Does Rhythm Pharmaceuticals, Inc. pay dividends?
- No, Rhythm Pharmaceuticals, Inc. does not pay dividends
- What sector is Rhythm Pharmaceuticals, Inc. in?
- Rhythm Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Rhythm Pharmaceuticals, Inc. in?
- Rhythm Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Rhythm Pharmaceuticals, Inc. based in?
- Rhythm Pharmaceuticals, Inc. is headquartered in United States
- When did Rhythm Pharmaceuticals, Inc. go public?
- Rhythm Pharmaceuticals, Inc. initial public offering (IPO) was on October 9, 2017
- Is Rhythm Pharmaceuticals, Inc. in the S&P 500?
- No, Rhythm Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Rhythm Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Rhythm Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Rhythm Pharmaceuticals, Inc. in the Dow Jones?
- No, Rhythm Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Rhythm Pharmaceuticals, Inc. last earnings report?
- Rhythm Pharmaceuticals, Inc.'s most recent earnings report was on August 4, 2026
- When does Rhythm Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Rhythm Pharmaceuticals, Inc. is November 3, 2026
Data Sources & References
- RYTM Official Website rhythmtx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1649904/000162828026012399/0001628280-26-012399-index.htm
- RYTM Profile on Yahoo Finance finance.yahoo.com/quote/RYTM
- RYTM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rytm